REAL WORLD DATA- USE OF NOVEL TREATMENTS AND BIOMARKERS IN MALIGNANT MELANOMA IN EUROPEAN COUNTRIES
Author(s)
von Bredow D1, Kolb N1, Bernhardt M2, Schmidt N2, Eheberg D3
1IMS Health GmbH & Co OHG, Munich, Germany, 2IMS Health GmbH & Co OHG, Frankfurt, Germany, 3IMS Health, Munich, Germany
OBJECTIVES:
Conference/Value in Health Info
2016-10, ISPOR Europe 2016, Vienna, Austria
Value in Health, Vol. 19, No. 7 (November 2016)
Code
PCN243
Topic
Health Service Delivery & Process of Care
Topic Subcategory
Prescribing Behavior
Disease
Oncology
Your browser is out-of-date
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now